Nicolle L E, Mayhew W J, Bryan L
Am J Med. 1987 Jul;83(1):27-33. doi: 10.1016/0002-9343(87)90493-1.
Fifty elderly (mean age, 83.4 +/- 8.8 years) institutionalized women with asymptomatic bacteriuria were randomly assigned either to receive therapy for treatment of all episodes of bacteriuria identified on monthly culture or to receive no therapy unless symptoms developed. Subjects were followed for one year. The therapy group had a mean monthly prevalence of bacteriuria 31 +/- 15 percent lower than those in the no-therapy group, but periods free of bacteriuria lasting six months or longer were documented for only five (24 percent) subjects. For residents receiving no therapy, 71 percent showed persistent infection with the same organism(s). Antimicrobial therapy was associated with an increased incidence of reinfection (1.67 versus 0.87 per patient-year) and adverse antimicrobial drug effects (0.51 versus 0.046 per patient-year) as well as isolation of increasingly resistant organisms in recurrent infection when compared with no therapy. No differences in genitourinary morbidity or mortality were observed between the groups. Thus, despite a lowered prevalence of bacteriuria, no short-term benefits were identified and some harmful effects were observed with treatment of asymptomatic bacteriuria. These data support current recommendations of no therapy for asymptomatic bacteriuria in this population.
五十名患有无症状菌尿症的老年(平均年龄83.4±8.8岁)机构养老女性被随机分为两组,一组接受治疗,对每月培养发现的所有菌尿症发作进行治疗,另一组除非出现症状否则不接受治疗。对受试者进行了一年的随访。治疗组菌尿症的平均每月患病率比未治疗组低31±15%,但只有五名(24%)受试者记录到无菌尿症持续六个月或更长时间。对于未接受治疗的居民,71%表现为同一病原体的持续感染。与未治疗相比,抗菌治疗与再感染发生率增加(每位患者每年1.67次对0.87次)、抗菌药物不良反应增加(每位患者每年0.51次对0.046次)以及复发性感染中分离出越来越耐药的病原体有关。两组之间在泌尿生殖系统发病率或死亡率方面未观察到差异。因此,尽管菌尿症患病率有所降低,但未发现短期益处,且无症状菌尿症治疗观察到了一些有害影响。这些数据支持目前对该人群无症状菌尿症不进行治疗的建议。